CLEAR
发表于 2025-3-23 13:35:38
Therapeutic Drug Monitoring (TDM) and Toxicological Studies in Alternative Biological Matrices,herapeutic drug monitoring (TDM) have, on the other hand, remained underappreciated. TDM has the potential to enhance patient outcomes while also lowering healthcare expenditures due to its unambiguous dose-response correlations. Two new approaches to TDM have emerged in recent years: target concent
粗鄙的人
发表于 2025-3-23 16:47:20
http://reply.papertrans.cn/83/8231/823025/823025_12.png
制定
发表于 2025-3-23 20:07:47
Reducing Toxicity in Critically Ill Patients by Using Therapeutic Drug Monitoring,ualization, we can minimize the toxicity in critically ill patients. These days, the patient and organism complexity demand precision dosing which can be achieved through therapeutic drug monitoring (TDM) services. TDM has proven to be an effective approach for dose individualization. Conventionally
Estrogen
发表于 2025-3-24 00:32:40
http://reply.papertrans.cn/83/8231/823025/823025_14.png
GREEN
发表于 2025-3-24 03:08:18
http://reply.papertrans.cn/83/8231/823025/823025_15.png
手段
发表于 2025-3-24 09:08:56
http://reply.papertrans.cn/83/8231/823025/823025_16.png
Abnormal
发表于 2025-3-24 12:44:49
Therapeutic Drug Monitoring and Toxicology: Relevance of Measuring Metabolites,taining drug concentrations below toxic levels. Although TDM has predominantly focused on determining the level of the parent drug compound in order to guide the dosing regimen, it is important to consider that some drugs are inactive in their parental forms and only their metabolites have therapeut
垫子
发表于 2025-3-24 16:54:32
Recent Advances in Nanosensors for Therapeutic Drug Monitoring (TDM),rials and nanotechnology for therapeutic drug monitoring (TDM) in order to meet the urgent need of measuring drug concentrations in biological matrices like plasma, serum, saliva, or urine, at a lower cost and within a shorter time period than traditional immunoassays or chromatographic methods. Dev
exacerbate
发表于 2025-3-24 21:27:12
,Organ Toxicity by Immunosuppressive Drugs in Solid Organ Transplantation,nction and provides improved quality of life together with its cost-effectiveness. During perioperative and post-transplant periods, organ transplant recipients receive immunosuppressive therapy, which reduces the high risk of allograft rejection, minimizes infections, improves allograft quality, an
热烈的欢迎
发表于 2025-3-25 01:06:11
http://reply.papertrans.cn/83/8231/823025/823025_20.png